Melatonin ameliorates some biochemical alterations following ketoconazole administration in rats.
Animals
Antifungal Agents
/ adverse effects
Central Nervous System Depressants
/ pharmacology
Disease Models, Animal
Follicle Stimulating Hormone
/ metabolism
Genitalia, Male
/ drug effects
Gonadotropin-Releasing Hormone
/ metabolism
Ketoconazole
/ toxicity
Luteinizing Hormone
/ metabolism
Male
Melatonin
/ pharmacology
Rats
Rats, Wistar
Spermatozoa
/ drug effects
Testis
/ drug effects
Testosterone
/ metabolism
hormone
ketoconazole
melatonin
sperm
toxicity
Journal
Journal of basic and clinical physiology and pharmacology
ISSN: 2191-0286
Titre abrégé: J Basic Clin Physiol Pharmacol
Pays: Germany
ID NLM: 9101750
Informations de publication
Date de publication:
11 Jan 2020
11 Jan 2020
Historique:
received:
02
06
2019
accepted:
22
10
2019
pubmed:
12
1
2020
medline:
1
5
2021
entrez:
12
1
2020
Statut:
epublish
Résumé
Background Ketoconazole (Keto), an antifungal drug and a common therapeutic option in the treatment of advanced prostate cancer, is known to cause reproductive dysfunctions. Like Keto, melatonin has antifungal and anticarcinogenic actions. Moreover, the hormone has been used to reverse the damaging effects of different toxicants on the reproductive system. Therefore, this study investigated the effects of Keto with/without melatonin on selected biomarkers in rats. Methods Forty rats of 10 animals per group were used in this study, which lasted for 6 weeks. The control group was administered with saline (0.1 mL/day), while group 2 was administered with Keto during the last 3 weeks of experiment; however, in groups 3 and 4, Keto was administered during the first 3 weeks; thereafter, they were administered with saline and melatonin, respectively, during the subsequent 3 weeks. Keto and melatonin were administered at 100 and 10 mg/kg b.w./day (p.o.), respectively. Results The central effects of Keto are independent of the follicle stimulating hormone (FSH) and prolactin; however, relative to the control group, the drug significantly decreased the gonadotrophin releasing hormone (GNRH) and the luteinizing hormone (LH), substantiated by the corresponding significant decreases in sperm count and sperm morphology. Keto caused significant elevations in malondialdehyde (MDA) and lactate dehydrogenase (LDH) and a significant decrease in catalase (CAT) compared with the control group. Moreover, the drug triggered pro-inflammatory events. In group 3 (Keto recovery), MDA and uric acid levels were returned to the baseline (i.e. control), but not GNRH, LH, C-reactive protein (CRP), LDH, and CAT. Treatment with melatonin after Keto administration caused significant increases in FSH, LH, superoxide dismutase, total antioxidant capacity (TAC), sperm count, and sperm morphology but significant decreases in MDA and CRP, relative to groups 2 and 3. Conclusions Melatonin ameliorates some biochemical alterations following ketoconazole administration.
Identifiants
pubmed: 31926082
doi: 10.1515/jbcpp-2019-0155
pii: /j/jbcpp.ahead-of-print/jbcpp-2019-0155/jbcpp-2019-0155.xml
doi:
pii:
Substances chimiques
Antifungal Agents
0
Central Nervous System Depressants
0
Gonadotropin-Releasing Hormone
33515-09-2
Testosterone
3XMK78S47O
Luteinizing Hormone
9002-67-9
Follicle Stimulating Hormone
9002-68-0
Melatonin
JL5DK93RCL
Ketoconazole
R9400W927I
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM